Optimizing diagnosis and treatment of infants with congenital heart disease and pneumonia: A 15 years’ experience
E. A. Degtyareva,
E. S. Pavlova,
D. U. Ovsannikov,
B. M. Mwela,
M. A. Kufa,
C. N. Sheiko,
G. N. Vavilova,
E. I. Kondratieva https://doi.org/10.31146/2949-4664-apps-2-1-56-67
Abstract
Pneumonia is the most frequent infectious intercurrent pathology in children with Congenital heart disease. It is the reason for forced postponement of life-saving cardiac surgery. Our fifteen years’ experience of children with congenital heart disease and pneumonia during the preoperative period, allows not only to predict the course of pneumonia in infants with CHD but also to provide an optimal algorithm for diagnosis and therapy to reduce the time of convalescences and preoperative preparation.
About the Authors
E. A. Degtyareva
Children’s Infectious Diseases Clinical Hospital No. 6 DZM; Peoples’ Friendship University of Russia, named after Patrice Lumumba
Russian Federation
Russian Federation
E. S. Pavlova
Children’s Infectious Diseases Clinical Hospital No. 6 DZM
Russian Federation
Russian Federation
D. U. Ovsannikov
Children’s Infectious Diseases Clinical Hospital No. 6 DZM; Peoples’ Friendship University of Russia, named after Patrice Lumumba
Russian Federation
Russian Federation
B. M. Mwela
Peoples’ Friendship University of Russia, named after Patrice Lumumba
Russian Federation
Russian Federation
M. A. Kufa
Children’s Infectious Diseases Clinical Hospital No. 6 DZM
Russian Federation
Russian Federation
C. N. Sheiko
Children’s Infectious Diseases Clinical Hospital No. 6 DZM
Russian Federation
Russian Federation
G. N. Vavilova
Children’s Infectious Diseases Clinical Hospital No. 6 DZM
Russian Federation
Russian Federation
E. I. Kondratieva
Research Clinical Institute of Childhood of the Moscow Region
Russian Federation
Russian Federation
References
1. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002 Jun 19;39(12):1890-900. doi: 10.1016/s0735-1097(02)01886-7.
2. Forrester M.B., Merz R. D. Descriptive epidemiology of selected congenital heart defects, Hawaii, 1986-1999. Paediatr Perinat Epidemiol. 2004 Nov;18(6):415-24. doi: 10.1111/j.1365-3016. 2004.00594.x.
3. Bokeria L., Shatalov K. [Pediatric cardiac Surgery: A guide for doctors]. Moscow. NCSSH named after AN Bakuleva. Bakuleva Scientific Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences. 2016, 864 p. (in Russ.)@@ Бокерия Л, Шаталов К. Детская кардиохирургия: Руководство для врачей. М: НЦССХ им АН Бакулева. 2016;864:-864 с.
4. Arvind B., Saxena A. Timing of Interventions in Infants and Children with Congenital Heart Defects. Indian J Pediatr. 2020 Apr;87(4):289-294. doi: 10.1007/s12098-019-03133-w.
5. Costello J.M., Pasquali S. K., Jacobs J. P. et al. Gestational age at birth and outcomes after neonatal cardiac surgery: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Circulation. 2014 Jun 17;129(24):2511-7. doi: 10.1161/CIRCULATIONAHA.113.005864.
6. Mavroudis C., Backer C., Anderson R. et al. Pediatric cardiac surgery: John Wiley & Sons. 2023.
7. Murni I.K., MacLaren G., Morrow D., Iyer P., Duke T. Perioperative infections in congenital heart disease. Cardiol Young. 2017 Dec;27(S6): S14-S21. doi: 10.1017/S1047951117002578.
8. Healy F., Hanna B. D., Zinman R. Pulmonary complications of congenital heart disease. Paediatr Respir Rev. 2012 Mar;13(1):10-5. doi: 10.1016/j.prrv.2011.01.007.
9. Habib G., Hoen B., Tornos P., Thuny F., Prendergast B., Vilacosta I., Moreillon P., de Jesus Antunes M., Thilen U., Lekakis J., Lengyel M., Müller L., Naber C. K., Nihoyannopoulos P., Moritz A., Zamorano J. L.; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009 Oct;30(19):2369-413. doi: 10.1093/eurheartj/ehp285.
10. Horeczko T., Green J. P., Panacek E. A. Epidemiology of the Systemic Inflammatory Response Syndrome (SIRS) in the emergency department. West J Emerg Med. 2014 May;15(3):329-36. doi: 10.5811/westjem.2013.9.18064.
11. Balamuth F., Weiss S. L., Neuman M. I. et al. Pediatric severe sepsis in U.S. children’s hospitals. Pediatr Crit Care Med. 2014 Nov;15(9):798-805. doi: 10.1097/PCC.0000000000000225.
12. Weiss S.L., Fitzgerald J. C., Pappachan J., Wheeler D., Jaramillo-Bustamante J.C., Salloo A., Singhi S. C., Erickson S., Roy J. A., Bush J. L., Nadkarni V. M., Thomas N. J.; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57. doi: 10.1164/rccm.201412-2323OC.
13. Singer M., Deutschman C. S., Seymour C. W. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
14. Watkins L. A.Interventions for Pediatric Sepsis and Their Impact on Outcomes: A Brief Review. Healthcare (Basel). 2018 Dec 28;7(1):2. doi: 10.3390/healthcare7010002.
15. Babu S., Sreedhar R., Munaf M., Gadhinglajkar S. V. Sepsis in the Pediatric Cardiac Intensive Care Unit: An Updated Review. J Cardiothorac Vasc Anesth. 2023 Jun;37(6):1000-1012. doi: 10.1053/j.jvca.2023.02.011.
16. Zelenikin M., Degtyareva E., Lobacheva G., Khakhina L. The importance of preoperative prevention of specific pneumonia in infected cardiac surgical patients in early childhood. Thoracic and cardiovascular surgery. 1997(5):27-30. (in Russ.)@@ Зеленикин М, Дегтярева Е, Лобачева Г, Хахина Л. Значение дооперационной профилактики специфических пневмоний у инфицированных кардиохирургических больных раннего возраста. Грудная и сердечно-сосудистая хирургия. 1997(5):27-30.
17. Murni I.K., MacLaren G., Morrow D., Iyer P., Duke T. Perioperative infections in congenital heart disease. Cardiol Young. 2017 Dec;27(S6): S14-S21. doi: 10.1017/S1047951117002578.
18. Degtyareva E, Pavlova E, Ovsyannikov D, Vavilova G. Pneumonia in infants with congenital heart defects. Pediatrics Journal named after G. Speransky. 2011;90(6):164. (in Russ.)@@ Дегтярева Е, Павлова Е, Овсянников Д, Вавилова Г. Пневмония у младенцев с врожденными пороками сердца. Педиатрия Журнал им ГН Сперанского. 2011;90(6):164.
19. Sadoh W.E., Osarogiagbon W. O. Underlying congenital heart disease in Nigerian children with pneumonia. Afr Health Sci. 2013 Sep;13(3):607-12. doi: 10.4314/ahs.v13i3.13.
20. Rahayuningsih S.E., Budi Kuswiyanto R., Reviyani Suryaningrat F., Nataprawira H. M., Sukadi A. Left to right shunt congenital heart disease as a risk factor of recurrent pneumonia in under five-year-old children: a single centre experience in Bandung Indonesia. Med Glas (Zenica). 2021 Feb 1;18(1):33-37. doi: 10.17392/1196-21.
21. Diller G.P., Enders D., Lammers A. E. et al. Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia. Heart. 2021 Jun 11;107(13):1069-1076. doi: 10.1136/heartjnl-2020-317706.
22. Jat N.K., Bhagwani D. K., Bhutani N., Sharma U., Sharma R., Gupta R. Assessment of the prevalence of congenital heart disease in children with pneumonia in tertiary care hospital: A cross-sectional study. Ann Med Surg (Lond). 2021 Nov 23;73:103111. doi: 10.1016/j.amsu.2021.103111.
23. Radford D.J., Thong Y. H. The association between immunodeficiency and congenital heart disease. Pediatr Cardiol. 1988;9(2):103-8. doi: 10.1007/BF02083708.
24. Degtiareva E.A., Samuilova D. Sh., Razuvaev M. K., Khurges I. S. Immunogematologicheskiĭ skrining i immunokorrektsiia v kardiokhirurgii rannego vozrasta [Immunohematologic screening and immunocorrection in cardiac surgery at an early age]. Biull Eksp Biol Med. 1993 Apr;115(4):393-6. (in Russ.)
25. Degtyareva E. A. [The importance of non - surgical factors in improving the results of surgical treatment of congenital heart defects]. diss…Doctor of Medical Sciences. Moscow. 1996, 45P. appendix 4. (in Russ.)@@ Дегтярева ЕА. Значение нехирургических факторов в улучшении результатов хирургического лечения врожденных пороков сердца. автореф дисс…д-ра мед.наук/ Дегтярева, Елена Александровна. M. 1996, 45с, приложение 4с 1996.
26. Wienecke L.M., Cohen S., Bauersachs J., Mebazaa A., Chousterman B. G. Immunity and inflammation: the neglected key players in congenital heart disease? Heart Fail Rev. 2022 Sep;27(5):1957-1971. doi: 10.1007/s10741-021-10187-6.
27. Singampalli K.L., Jui E, Shani K. et al. Congenital Heart Disease: An Immunological Perspective. Front Cardiovasc Med. 2021 Aug 9;8:701375. doi: 10.3389/fcvm.2021.701375.
28. Degtyareva E.A., Prodeus A. P., Mwela B. M., Kim A. I., Nefedova I. E., Rogova T. V. et al. New methods of preoperative diagnosis of immunological insufficiency in children with congenital heart defects, for the prediction and prevention of infectious complications of cardiac surgery. The second All-Russian Congress of Pediatric Cardiac Surgeons and Specialists in Congenital Heart defects (with international participation) 07-09 September 2023, Volgograd. Collection of abstracts.st 842023.@@ Дегтярева Е. А., Продеус А. П., Мвела Б. М., Ким А. И., Нефедова И. Е., Рогова Т. В., et al. Новые методы дооперционной диагностики иммунологической недостаточности у детей с врожденными пороками сердца для прогнозирования и профилактики инфекционных осложнений кардиохирургии. Второй Всероссийский съезд детских кардиохирургов и специалистов по врожденным порокам сердца (с международным участием) 07-09 сентября 2023, г. Волгоград. Сборник тезисов.ст 842023.
29. Samsyginа G. А. Respiratory tract infections in infants. Мoscow. 2006; 224-228. (in Russ.)@@ Инфекции респираторного тракта у детей раннего возраста. Под редакцией проф. Самсыгиной Г. А. М; 2006; 224-228.
30. Ovsyannikov D.Y. M. Karpenko M. A. [Pneumonia in Pediatrics: textbook: in 5 volumes]. Edd. D. Y. Ovsyannikov. Moscow.RUDN Publ., 2021, Vol. 2: Otorhinolaryngology, pulmonology, hematology, immunology, pp. 264-314. (in Russ.)@@ Овсянников Д. Ю., Карпенко М. А. Пневмонии. В кн.: Педиатрия: учебник: в 5 томах / под редакцией Д. Ю. Овсянникова. М.: РУДН, 2021. Т. 2: Оториноларингология, пульмонология, гематология, иммунология. С. 264-314.
31. Community-acquired pneumonia in children. Clinical recommendations. Moscow. Original layout. 2015. 64 p. (in Russ.)@@ Внебольничная пневмония у детей. Клинические рекомендации. - М.: Оригинал-макет, 2015. - 64 с.
32. Ovsyannikov D.Y., Pavlova E. S., Degtyaryova E. A. et al. [Informational content of a method of a high-allowing computer tomography in differential diagnostics of focal radiological changes at children with congenital heart diseases]. VII All-Russian Congress “Children’s cardiology 2012”. Theses Publ., Moscow. 2012; 283-284. (in Russ.)@@ Овсянников Д. Ю., Павлова Е. С., Дегтярёва Е. А. et al. Информативность метода высокоразрешающей компьютерной томографии в дифференциальной диагностике очаговых рентгенологических изменений у детей с врождёнными пороками сердца. VII Всероссийский Конгресс «Детская кардиология 2012». Тезисы; М; 2012; 283-284.
33. Raju S., Ghosh S., Mehta A. C. Chest CT Signs in Pulmonary Disease: A Pictorial Review. Chest. 2017 Jun;151(6):1356-1374. doi: 10.1016/j.chest.2016.12.033.
34. Galiè N., Humbert M., Vachiery J. L. et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002.
35. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2023 Apr 17;44(15):1312. doi: 10.1093/eurheartj/ehad005.
36. Degtyareva E.A., Pavlova E. S., Rytchenkova A. E. [Diagnostic significance of natriuretic peptides in infants with congenital heart defects and pneumonia]. VII All-Russian Congress “Pediatric Cardiology 2012”.Theses Publ., Moscow. 2012; 19-20. (in Russ.)@@ Дегтярёва Е. А., Павлова Е. С., Рытченкова А. Е. Диагностическая значимость натрийуретических пептидов у младенцев с врождёнными пороками сердца и пневмонией. VII Всероссийский Конгресс «Детская кардиология 2012». Тезисы. М; 2012; 19-20.
37. Cantinotti M., Walters H. L., Crocetti M., Marotta M., Murzi B., Clerico A. BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? Cardiol Young. 2015 Mar;25(3):424-37. doi: 10.1017/S1047951114002133.
38. Gokulakrishnan G., Kulkarni M., He S., Leeflang M. M., Cabrera A. G., Fernandes C. J., Pammi M. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates. Cochrane Database Syst Rev. 2022 Dec 8;12(12): CD013129. doi: 10.1002/14651858.CD013129.pub2.
Review
For citations:
Degtyareva E.A., Pavlova E.S., Ovsannikov D.U., Mwela B.M., Kufa M.A., Sheiko C.N., Vavilova G.N., Kondratieva E.I. Optimizing diagnosis and treatment of infants with congenital heart disease and pneumonia: A 15 years’ experience. Archives of Pediatrics and Pediatric Surgery. 2024;2(1):56-67. (In Russ.) https://doi.org/10.31146/2949-4664-apps-2-1-56-67
Views:
231
Email this article 